(Q34989707)

5 August 2017

1 reference

title

Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice (English)

1 reference

5 August 2017

0 references

cardiovascular disease

1 reference

James S Zebrack

1

1 reference

5 August 2017

Jeffrey L Anderson

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2002

1 reference

Progress in Cardiovascular Nursing

5 August 2017

published in

1 reference

5 August 2017

volume

17

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

174-185

1 reference

Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

C-reactive protein as a marker for acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Exercise and risk of stroke in male physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Therapeutic interventions to lower plasma fibrinogen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0889-7204.2002.1118.X

10.1111/J.0889-7204.2002.1118.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference